Life Science News

RSS

Horizon Discovery enters into licensing agreement with NGM for GS knockout CHO K1 cell line

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will license its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line to NGM Biopharmaceuticals, Inc..

From Revvity 22 Jan 2020

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect system.

22 Jan 2020

New approach for the manufacture of Advanced Therapy Medicinal Products

Akron Biotechnology has proposed a new approach for the qualification of ancillary materials for the manufacture of Advanced Therapy Medicinal Products.

22 Jan 2020

New software that provides increased visualization tools for labs

Biosero, Inc. will release new software products and features, at the 2020 Society for Laboratory Automation and Screening Conference (SLAS 2020).

From Biosero Inc. 22 Jan 2020

High-speed, precise liquid and gas handling products at SLAS 2020

Festo debuts a new generation of high speed, flexible, and precise liquid dispensing and gas handling products at SLAS, January 27-29, in San Diego.

22 Jan 2020

New method determines the atomic structure of natural products more rapidly, accurately

Many drugs are derived from natural products. But before natural products can be exploited, chemists must first determine their structure and stereochemistry.

21 Jan 2020

Researchers estimate mortality costs associated with air pollution in the U.S.

A team of University of Illinois researchers estimated the mortality costs associated with air pollution in the U.S. by developing and applying a novel machine learning-based method to estimate the life-years lost and cost associated with air pollution exposure.

21 Jan 2020

Powerful combination of experimental drugs reverses osteoarthritis in rats

People with osteoarthritis, or "wear and tear" arthritis, have limited treatment options: pain relievers or joint replacement surgery.

21 Jan 2020

Researchers discover how bacterial pathogens switch into attack mode

Many bacterial pathogens excrete toxins as soon as they have entered the host in order to suppress its immune response.

21 Jan 2020

NAU scientists study zebrafish to find powerful melanoma-fighting drugs

Melanoma is the most lethal type of skin cancer and unusually common in Arizona, where residents are exposed to higher-than-average amounts of ultraviolet radiation. However, Northern Arizona University scientists believe the formula for a combination of melanoma-fighting drugs is within reach.

21 Jan 2020

Informative white paper demonstrates benefits of novel EAF4 technology

An informative white paper from Postnova Analytics demonstrates how its novel Electrical and Asymmetrical Field Flow Fractionation (EAF4) technology can be used to separate a wide variety of nano-sized materials while simultaneously determining surface charge.

From Postnova Analytics 21 Jan 2020

New technology systematically identifies drug targets in living animals

Developing new medicines and understanding how they target specific organs often gives a crucial advantage in the fight against human diseases.

21 Jan 2020

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Turbine, a simulation-first drug discovery company, today announced the formation of its Scientific Advisory Board with the appointments of Dr. Annalisa Jenkins, Dr. Mihriban Tuna, and Dr. Alan Barge.

21 Jan 2020

Enterprise Therapeutics publishes open access paper on novel approach to treat cystic fibrosis

Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, today announced the publication of its first peer-reviewed paper.

21 Jan 2020

Life Science News

Horizon Discovery enters into licensing agreement with NGM for GS knockout CHO K1 cell line

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

New approach for the manufacture of Advanced Therapy Medicinal Products

New software that provides increased visualization tools for labs

High-speed, precise liquid and gas handling products at SLAS 2020

New method determines the atomic structure of natural products more rapidly, accurately

Researchers estimate mortality costs associated with air pollution in the U.S.

Powerful combination of experimental drugs reverses osteoarthritis in rats

Researchers discover how bacterial pathogens switch into attack mode

NAU scientists study zebrafish to find powerful melanoma-fighting drugs

Informative white paper demonstrates benefits of novel EAF4 technology

New technology systematically identifies drug targets in living animals

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Enterprise Therapeutics publishes open access paper on novel approach to treat cystic fibrosis

SITESEEKER to be used for Otsuka’s therapeutics discovery programs

Certain enzymes implicated in diseases like cancer also destroy each other

Linkam automated temperature-controlled stage supports TASC method for rapid screening of drug-polymer miscibility

Refining pathological classification of breast cancer using multiplexed imaging

Researchers discover new regions of non-coding DNA that may lead to cancer growth

Researchers develop self-assembled artificial microtubule like LEGO building blocks

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News